Randomized Phase II Trial of Erlotinib Beyond Progression in Advanced Erlotinib-Responsive Non-Small Cell Lung Cancer

por Halmos, Balazs, Pennell, Nathan A., Fu, Pingfu, Saad, Shumaila, Gadgeel, Shirish, Otterson, Gregory A., Mekhail, Tarek, Snell, Michael, Kuebler, J. Philip, Sharma, Neelesh, Dowlati, Afshin
Publicado en Oncologist (2015)

Phase I Trial of Fludarabine, Bortezomib and Rituximab for Relapsed and Refractory Indolent and Mantle Cell Non-Hodgkin Lymphoma

por Barr, Paul M., Fu, Pingfu, Lazarus, Hillard M., Horvath, Nancy, Gerson, Stanton L., Koc, Omer N., Bahlis, Nizar J., Snell, Michael R., Dowlati, Afshin, Cooper, Brenda W.
Publicado 2009